← SynDRA
GSK429286A
SynDRA canonical compound SYN1970476 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ROCK1 |
|---|
| Mechanism of action | rho associated kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- rho associated kinase inhibitor
Cross-references
Synonyms
- RHO-15
- N-(6-fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide
- GSK-429286
- N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide
- C21H16F4N4O2
- N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)-phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide
- N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyridine-3-carboxamide
- dihydropyridone indazole
- CHEMBL375312
- GTPL9356
- SCHEMBL2801740
- BDBM14055
- CHEBI:91332
- dihydropyridone indazole amide 15
- DTXSID70463946
- BCPP000217
- HMS3244C07
- HMS3244C08
- HMS3244D07
- HMS3265C03
- HMS3265C04
- HMS3265D03
- HMS3265D04
- HMS3654N12
- HMS3750C21
- AMY39943
- BCP01975
- EX-A1119
- GSK-429286A
- GSK 429286 A
- HB2290
- MFCD16618404
- s1474
- AKOS024457773
- BCP9000743
- CCG-269030
- CS-0095
- compound 15 [PMID: 17201405]
- NCGC00346096-02
Look up GSK429286A in the interactive SynDRA portal →